Krajina: Malta
Jazyk: angličtina
Zdroj: Medicines Authority
Bialport Produtos Farmaceuticos S.A. A Avenida Da Siderurgia Nacional Sao Mamede De Coronado Trofa,Porto, Portugal
J01DD08
CEFIXIME 100 mg/5ml
POWDER FOR ORAL SUSPENSION
CEFIXIME 100 mg/5ml
POM
ANTIBACTERIALS FOR SYSTEMIC USE
Authorised
2024-02-16
PACKAGE LEAFLET: INFORMATION FOR THE USER TRICEF 400 MG FILM-COATED TABLETS TRICEF 20 MG/ML POWDER FOR ORAL SUSPENSION Cefixime READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, or pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Tricef is and what it is used for 2. What you need to know before you take Tricef 3. How to take Tricef 4. Possible side effects 5. How to store Tricef 6. Contents of the pack and other information 1. WHAT TRICEF IS AND WHAT IT IS USED FOR The active substance of TRICEF (film-coated tablets and powder for oral suspension) is cefixime, an antibiotic belonging to the 3rd generation cephalosporin group. TRICEF acts causing the death of bacteria that develop infections. Its use is indicated in the following infections, when those bacteria are thought to be susceptible to the drug: - Acute otitis media; - Upper respiratory tract infections (pharyngitis, tonsillitis, acute sinusitis); - Lower respiratory tract infections (acute exacerbations of chronic bronchitis, community acquired pneumonia); - Urinary tract infections (acute cystitis, uncomplicated acute pyelonephritis); - Uretritis and uncomplicated gonococcal cervicitis. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TRICEF DO NOT TAKE TRICEF - if you are allergic (hypersensitive) to cefixime or any antibiotics belonging to the penicillin group (beta-lactam).There is a rare chance to occur a severe allergic, and sudden, reaction (anaphylaxis/anaphylactic shock) even with the first dose of this class of antibiotics. The symptoms can be chest tightness, dizziness, malaise, fa Prečítajte si celý dokument
Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF MEDICINAL PRODUCT Tricef 20 mg/mL powder for oral suspension. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 mL of oral suspension contains 100 mg of cefixime. Excipient with known effect: Sucrose – 505.022 mg/mL For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Powder for oral suspension. Powder for oral suspension, white to pale cream colored and strawberry odor. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Tricef is indicated for the treatment of the following infections caused by susceptible agents (see section 4.4 and 5.1): - Acute otitis media - Upper respiratory tract infections (pharyngitis, tonsillitis, acute sinusitis) - Lower respiratory tract infections (acute exacerbations of chronic bronchitis, community acquired pneumonia); - Urinary tract infections (acute cystitis, uncomplicated acute pyelonephritis); - Uretritis and uncomplicated gonococcal cervicitis. Consideration should be given to national and/or local guidelines on the appropriate use of antibiotics. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The usual recommended posology is 8 mg/kg, single dose. In terms of the pharmaceutical form, the dosage is generally as follows: - _Children aged 2-4 years_ : 1 measuring spoon every 24h; ½ measuring spoon every 12 hours. - _Children aged 5-8 years_ : 2 measuring spoons every 24h; 1 measuring spoon every 12 hours. - _Children aged 9-12 years_ : 3 measuring spoons every 24h; 1½ measuring spoon every 12 hours. - _Patients with renal impairment_ : The medicine may be administered to patients with impaired renal function. Doses indicated above may be given in patients with creatinine clearance of 20 Page 2 of 9 mL/min or above. In patients whose creatinine clearance is less than 20 mL/min, it is recommended not to exceed a daily dose of 200 mg. This dose should also not be exceeded in patients undergoing chronic peritoneal dialysis or hemodialysis, since cefixime is slowly removed from circulation by dialysis. In Prečítajte si celý dokument